SE0001373D0 - NPY Y1 receptor agonists and antagonists - Google Patents

NPY Y1 receptor agonists and antagonists

Info

Publication number
SE0001373D0
SE0001373D0 SE0001373A SE0001373A SE0001373D0 SE 0001373 D0 SE0001373 D0 SE 0001373D0 SE 0001373 A SE0001373 A SE 0001373A SE 0001373 A SE0001373 A SE 0001373A SE 0001373 D0 SE0001373 D0 SE 0001373D0
Authority
SE
Sweden
Prior art keywords
npy
antagonists
receptor agonists
relates
receptor
Prior art date
Application number
SE0001373A
Other languages
English (en)
Inventor
Patrik Ernfors
Philippe Naveilhan
Lucas Guilherme De Araujo
Hessameh Hassani
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE0001373A priority Critical patent/SE0001373D0/sv
Publication of SE0001373D0 publication Critical patent/SE0001373D0/sv
Priority to PCT/SE2001/000828 priority patent/WO2001078763A1/en
Priority to CA002405600A priority patent/CA2405600A1/en
Priority to US10/257,667 priority patent/US20030153487A1/en
Priority to EP01922198A priority patent/EP1276498A1/en
Priority to AU2001248972A priority patent/AU2001248972A1/en
Priority to PCT/SE2001/000827 priority patent/WO2001078762A1/en
Priority to AU2001248971A priority patent/AU2001248971A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2271—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
SE0001373A 2000-04-13 2000-04-13 NPY Y1 receptor agonists and antagonists SE0001373D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0001373A SE0001373D0 (sv) 2000-04-13 2000-04-13 NPY Y1 receptor agonists and antagonists
PCT/SE2001/000828 WO2001078763A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
CA002405600A CA2405600A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
US10/257,667 US20030153487A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
EP01922198A EP1276498A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
AU2001248972A AU2001248972A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
PCT/SE2001/000827 WO2001078762A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor agonists in the treatment of pain conditions
AU2001248971A AU2001248971A1 (en) 2000-04-13 2001-04-12 Use of npy y1 receptor agonists in the treatment of pain conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001373A SE0001373D0 (sv) 2000-04-13 2000-04-13 NPY Y1 receptor agonists and antagonists

Publications (1)

Publication Number Publication Date
SE0001373D0 true SE0001373D0 (sv) 2000-04-13

Family

ID=20279307

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001373A SE0001373D0 (sv) 2000-04-13 2000-04-13 NPY Y1 receptor agonists and antagonists

Country Status (6)

Country Link
US (1) US20030153487A1 (sv)
EP (1) EP1276498A1 (sv)
AU (2) AU2001248972A1 (sv)
CA (1) CA2405600A1 (sv)
SE (1) SE0001373D0 (sv)
WO (2) WO2001078763A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2262567T3 (es) * 2001-03-20 2006-12-01 Schwarz Pharma Ag Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico.
PT1243263E (pt) 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
NZ546576A (en) 2003-12-02 2009-05-31 Sanol Arznei Schwarz Gmbh Use of peptide compounds for treating central neuropathic pain
KR20070007931A (ko) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
WO2005114213A2 (en) * 2004-05-21 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy1 (npy1)
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
JP2008510758A (ja) 2004-08-27 2008-04-10 シュヴァルツ・ファーマ・アーゲー 骨肉腫の痛み、化学療法誘発性及びヌクレオシド誘発性の痛みを治療するためのペプチド化合物の新規使用
MX2008016000A (es) 2006-06-15 2009-03-05 Sanol Arznei Schwarz Gmbh Composicion farmaceutica con efecto anticonvulsivante sinergistico.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569742A (en) * 1994-06-22 1996-10-29 The Salk Institute For Biological Studies Centrally truncated NPY cyclic peptides

Also Published As

Publication number Publication date
AU2001248972A1 (en) 2001-10-30
EP1276498A1 (en) 2003-01-22
WO2001078763A1 (en) 2001-10-25
US20030153487A1 (en) 2003-08-14
CA2405600A1 (en) 2001-10-25
AU2001248971A1 (en) 2001-10-30
WO2001078762A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
MXPA04000707A (es) Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas.
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
GEP20104962B (en) Fused heterocyclic compounds
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
DE69922676D1 (de) N-aralkylaminotetraline als neuropeptid-y-y5-rezeptorliganden
WO2007011878A3 (en) Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
DK1373256T3 (da) CCR5-antagonister, der er nyttige til behandling af AIDS
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
DE60314896D1 (de) 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert
AR028579A1 (es) Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica
ATE325124T1 (de) Ccr1-rezeptor-antagonisten zur behandlung u.a. demyelinisierender entzündlicher erkrankungen
DK1492773T3 (da) 4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation
SE0001373D0 (sv) NPY Y1 receptor agonists and antagonists
DE69922528D1 (de) N-imidazolyl-alkyl substituierte cyklische amine als histamin-h3 agonisten oder antagonisten
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
ATE406373T1 (de) Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
ATE282041T1 (de) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
ATE401331T1 (de) 6h-thienä2,3-büpyrrolderivate als antagonisten des gonadotropin-freisetzenden hormons (gnrh)